Anterior Temporal Epilepsy Neuropsychological Assessment of Faces
Not Applicable
- Conditions
- Anterior Temporal LobectomyAnterior Temporal EpilepsyFace Perception
- Registration Number
- NCT02888925
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
The purpose is to evaluate neuropsychological effects of anterior temporal epilepsy in face perception by comparison of performances of epileptic patients and control individuals, sex-, age- and socio-educational level-matched.
Secondary purposes are to prospectively evaluate neuropsychological impact of anterior temporal lobectomy performed for surgical treatment of anterior temporal epilepsy on face perception (exploratory study).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
ALL:
- Informed consent
- Affiliation to social security
- Preliminary medical examination
PATIENTS WITH EPILEPSY:
- Symptomatic drug-resistant anterior temporal epilepsy (confirmed with video-electroencephalography and magnetic resonance imaging and if necessary intracerebral SEEG exploration)
- Patient needing anterior temporal lobectomy and undergoing pre-surgery conventional intercritical assessment for surgery decision
- Nonverbal IQ ≥ 70 (WAIS-IV)
- At least 6 successful VOSP tests (perception test)
Exclusion Criteria
ALL:
- persons under legal protection or incapable to consent
- Persons deprived of liberty by juridical or administrative decision
PATIENTS WITH EPILEPSY:
- Sever visual disorders of neurological or ophthalmological origin
CONTROL INDIVIDUALS:
- Psychiatric or neurological disorders
- Important ophthalmological disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Scores obtained with Benton test by patients with anterior temporal epilepsy and matched control individuals day 0
- Secondary Outcome Measures
Name Time Method Change of scores obtained with Benton test by epilepsy patients before and after lobectomy and control individuals (only patients having undergone anterior temporal lobectomy and matched control individuals) day 0 and after 24 to 30 months
Trial Locations
- Locations (1)
Service de Neurologie, Hôpital Central, CHU de Nancy
🇫🇷Nancy, France
Service de Neurologie, Hôpital Central, CHU de Nancy🇫🇷Nancy, France